Recs

15

4-Star Stocks Poised to Pop: Ashland

Based on the aggregated intelligence of 130,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, diversified chemical maker Ashland (NYSE: ASH  ) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Ashland's business, and see what CAPS investors are saying about the stock right now.

Ashland facts

Headquarters (founded)

Covington, Kentucky (1918)

Market Cap

$705.1 million

Industry

Diversified Chemicals

TTM Revenue

$8.44 billion

Management

Chairman/CEO James O'Brien (since 2002)

CFO Lamar Chambers (since 2008)

Business Segments

Performance Materials, Distribution, Valvoline, Water Technologies

Return on Capital (average, last three years)

3.1%

Dividend Yield

3.1%

Competitors

Rohm & Haas (NYSE: ROH  )

ExxonMobil (NYSE: XOM  )

CAPS members bullish on ASH also bullish on

Freeport-McMoRan (NYSE: FCX  )

ConocoPhillips (NYSE: COP  )

CAPS members bearish on ASH also bearish on

Caterpillar (NYSE: CAT  )

Pfizer (NYSE: PFE  )

Sources: Capital IQ, a division of Standard & Poor's, and Motley Fool CAPS. TTM = trailing 12 months.

Over on CAPS, fully 244 of the 266 members who have rated Ashland -- some 92% -- believe the stock will outperform the S&P 500 going forward. These bulls include All-Star GirlScoutDad, who is ranked in the top 10% of our community, and TSIF.

Last month, GirlScoutDad tapped the stock as an interesting income opportunity: "solid fundamentals, secure dividend = poised to grow with the eventual recovery."

In a pitch from January, TSIF also highlights Ashland as a good bet to rise from the ashes:

Ashland, highly diversified, is in enough of the WRONG industries that it's taken a beating. Despite the loss last quarter and the low margins Ashland is still very strong financially with good cash flow and very reasonable debt. Their oil filter and oil change segment ... may take a slight recession hit, but the products are still needed. Lower oil prices should actually help. The other segments should do well with a moderate recovery.

I haven't done the ashy work on Ashland yet, but there's a good chance the company is trading at a substantial discount to the sum of its parts. The stock currently sits at a paltry price-to-book of 0.2, and as yet another bull, BSHumphreyII, puts it, "Valvoline alone has to be worth almost half a billion. Big-time buy."

Ashland's been gradually moving out of its non-core segments (refining and construction) over the last few years to focus on chemicals, so heaps of that hidden value could be unlocked with further asset sales. Still, with a price tag of 1.3 times cash flow, it's tough to envision how patient Fools won't see a return of and on their capital over time -- breakup or not.

But what do you think about Ashland, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. More than 130,000 investors are waiting to hear what you have to say. CAPS is 100% free, so simply click here to get started.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Pfizer is a Motley Fool Inside Value selection. The Fool's disclosure policy always gets a perfect score.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 862191, ~/Articles/ArticleHandler.aspx, 2/15/2012 4:48:50 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 6 hours ago Sponsored by:
DOW 12,878.28 4.24 0.03%
S&P 500 1,350.50 -1.27 -0.09%
NASD 2,931.83 0.44 0.02%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 4:01 PM
ASH $63.74 Down -0.79 -1.22%
Ashland, Inc. CAPS Rating: ****
PFE $21.33 Up +0.03 +0.14%
Pfizer, Inc. CAPS Rating: ****
ROH $78.94 Down +0.00 +0.00%
Rohm and Haas Comp… CAPS Rating: **
XOM $84.67 Up +0.25 +0.30%
ExxonMobil Corp CAPS Rating: ****
CAT $114.45 Up +0.75 +0.66%
Caterpillar, Inc. CAPS Rating: ****
COP $73.60 Up +0.79 +1.09%
ConocoPhillips CAPS Rating: *****
FCX $42.96 Down -1.70 -3.81%
Freeport-McMoRan C… CAPS Rating: ****

Advertisement